{"uuid": "31faf148-374d-33f5-ed56-15aefa780875", "state": {"code": "confirmed", "et": "Kinnitatud", "en": "confirmed"}, "last_update": "2024-10-24T14:04:58", "title": {"en": "Pharmaceutical Nanotechnology", "et": "Farmatseutiline nanotehnoloogia"}, "credits": 4, "credit_type": "ECTS", "target": {"year": {"code": "2024", "et": "2024/2025", "en": "2024/2025"}, "semester": {"code": "spring", "et": "kevad", "en": "spring"}, "study_type": {"code": "fulltime", "et": "päevaõpe", "en": "regular studies"}, "language": {"code": "en", "et": "inglise keel", "en": "English"}, "part": {"code": "0", "et": "Osadeta", "en": "None"}, "faculty": {"code": "MV", "name": {"en": "Faculty of Medicine", "et": "meditsiiniteaduste valdkond"}, "address": "Tartu linn, \nTartu linn, Tartumaa \nEST", "city": "Tartu linn", "level": 1, "academic": true, "supports_continuous_learning": true}, "course_main_structural_unit": {"code": "MVFA", "name": {"en": "Institute of Pharmacy", "et": "farmaatsia instituut"}, "email": "pharmacy@ut.ee", "phone": "+372 737 5286", "webpage_url": "https://farmaatsia.ut.ee", "address": "Nooruse 1\n50411 Tartu linn, \nTartu linn, Tartumaa \nEST", "city": "Tartu linn", "street": "Nooruse 1", "zip": "50411", "level": 2, "academic": true, "supports_continuous_learning": true, "parent_code": "MV"}, "label": {"en": "24/25 S regular MV Eng", "et": "24/25 K PÕ MV Eng"}}, "general": {"year": {"code": "2024", "et": "2024/2025", "en": "2024/2025"}, "input_languages": [{"code": "et", "et": "eesti keel", "en": "Estonian"}], "structural_unit_shares": [{"structural_unit_code": "MVFA", "structural_unit_name": {"en": "Institute of Pharmacy", "et": "farmaatsia instituut"}, "course_share_percent": 100, "coordinating": true}], "type": {"code": "regular", "et": "Tavaline aine", "en": "Regular course"}}, "additional_info": {"is_vota_course": false, "is_continuous_learning_course": false, "study_levels": [{"code": "doctoral", "et": "doktoriõpe", "en": "doctoral studies"}, {"code": "bachelor_master", "et": "integreeritud bakalaureuse- ja magistriõpe", "en": "integrated bachelor's and master's studies"}], "hours": {"lecture": 36, "practice": 0, "seminar": 4, "independent_work": 64, "individual_work": 0, "internship": 0}, "is_enlight_course": true}, "overview": {"study_languages": [{"code": "et", "et": "eesti keel", "en": "Estonian"}, {"code": "en", "et": "inglise keel", "en": "English"}], "description": {"en": "This course provides an advanced-level approach to the scientific principles, methodologies, formulation, processing, applications, recent trends, and emerging technologies in the research of nanoparticulate drug delivery systems. The course will provide an insight into (but not limited) parenteral, oral, topical, pulmonary, ocular nanotechnology-based drug delivery systems and their therapeutic uses, biological requirements for nano-therapeutic applications, the role of nano-biotechnology in the development of nanomedicine, and recent advances and future perspectives in pharmaceutical nanoparticulate technology.", "et": "See kursus on mõeldud täiendavaks teadmiste omandamiseks nanoosaksestest valmistatud ravimite kandursüsteemide disainimise teaduslike printsiipide, meetodite, disaini, tootmise, kasutamise kohta. Tutvustatakse olemasolevaid ja arendatavaid tehnoloogiaid.\nKursuse käigus tutvutakse parenteraalsele, suukaudsete, lokaalsete, inhaleeritavate ja silma manustatavate (ja mitte ainult) nanotehnoloogial baseeruvate ravimite kandursüsteemidega ja nende kasutamisvõimalustega, neile esitatavate nõuete, nanobiotehnoloogial põhinevate ravimite hetkeseisu ja tulevikuperspektiividega."}, "objectives": [{"en": "The course aims to provide an advanced level of knowledge on the scientific methodologies, formulation, processing, applications, recent trends, and emerging technologies in the research of nanoparticulate drug delivery systems. The course presents a wide range of nanotechnology-based drug delivery systems and therapeutic uses, biological requirements for nanotherapeutic applications, the role of nanobiotechnology in the development of nanomedicine, and recent advances and future perspectives in pharmaceutical nanoparticulate technology.", "et": "Kursus annab ülevaate nanoosaksetel põhinevate ravimite kandursüsteemide uurimise teaduslikest meetoditest, nende disainimise ja tootmise hetkeseisust ning tulevikusuundadest.\nKursusel tutvustatakse nanotehnoloogial põhinevaid ravimite kandursüsteeme ja terapeutilisi lähenemisi, neile esitatavaid bioloogilisi nõudeid. Räägitakse nanobiotehnoloogia kohast nanoravimite arendamisel ja farmatseutilise nanotehnoloogia arengust."}], "learning_outcomes": [{"en": "The MSc/PhD student who has passed the course:", "et": "Kursuse läbinud üliõpilane/doktorant: "}, {"en": "-\tknows the classification and types of nanoparticulate drug delivery systems", "et": " - teab ravimite kandursüsteemide klassifikatsiooni ja nanoosakeste tüüpe;"}, {"en": "-\thave an overview on the different therapeutic applications and route of administration of nanoparticulate drug delivery systems (including gene delivery and vaccination)", "et": "- omab ülevaadet erinevatest nano\tsüsteemidest, nende manustamisviisidest ja kasutamisest (kaasa arvatud geeniteraapia ja vaktsineerimine);"}, {"en": "-\tknows the materials, technologies and challenges related to the formulation and characterization of nanoparticulate drug delivery systems ", "et": "- oskab nanosüsteeme iseloomustada, tunneb kasutatavaid materjale, tehnoloogiaid ning nende valmistamisega seotud probleeme;"}, {"en": "-\tknows the biological requirements for nano therapeutic applications", "et": "- teab nanoterapeutiliste vahendite kasutamise bioloogilisi nõudeid;"}, {"en": "-\tmodified-release drug delivery systems", "et": "- tunneb modifitseeritud vabanemisega ravimite kandursüsteeme;"}, {"en": "-\tknows the nanotoxicity and regulatory aspects related to the nanoparticulate drug delivery systems ", "et": "- teab nanosüsteemidega seotud nanotoksilisusest ja regulatoorsetest aspektidest;"}, {"en": "-\tunderstand the added value of any developed nanoparticulate drug delivery system (intellectual property aspects).", "et": "- mõistab arendatud nanosüsteemidega seotud intellektuaalse omandi küsimusi."}], "notes": {"et": "Kontakt isik / Contact person - prof. Jyrki Tapio Heinämäki (vastutav/responsible)\nProf. Jyrki Heinämäki, Institute of Pharmacy, room 715, tel. 7375281, email -  jyrki.heinamaki@ut.ee"}}, "grading": {"independent_work": {"et": "Regular subject. Lectures, seminars, scientific article reviews .\nIn the seminar session (xx.xx.), 15-20 min student presentations based on research articles in Pharmaceutical nanotechnology."}, "independent_work_assessments": [{"work_type": {"code": "written", "et": "Kirjalik lõpphindamine", "en": "final written assessment"}, "description": {"et": "eksam\nFinal exam (A,B,C,D,E,F)"}}], "grade_preconditions": {"et": "Võlgnevusi ei ole"}, "grade_evaluation": {"et": "eksam (A,B,C,D,E,F).\nFinal exam (A,B,C,D,E,F)\nThere is a written examination in the end of the course. Completing the learning assignments is required for passing the course\n\n\nA - Excellent (91-100%):\tThe student shows an excellent knowledge on the course topic area and substance. The anwers are exceptionally well and precisely compiled, logically presented, and correct. The language is also perfect.   \n\nB - Very good (81-90%):\tThe student shows very good knowledge on the course \ntopic area and substance. The anwers are well written  and mainly correct. The language is also good without any significant flaws.   \n \nC - Good (71-80%): \tThe student shows a good knowledge on the course  topic area and substance. The anwers are quite well compiled and mainly correct. The language is also quite good with only some flaws.   \n\nD - Satisfactory (61-70%):\tThe student shows satisfactory knowledge on the  course topic area and substance. The anwers contain  some siginificant deficiences and flaws. The language is only fair to passable with clear mistakes.   \n\nE - Passable (51-60%): \tThe student shows only a fair and passable knowledge on the course topic area and substance. The anwers contain many deficiences. The language is quite poor with numerous flaws.   \n\nF - Rejected (0-50%): \tThe student shows very poor knowledge on the course topic area and substance. The anwers contain numerous significant flaws and deficiences. The language is very poor with numerous flaws."}, "debt_elimination": {"et": "Kokkuleppel õppejõuga\nKontakt isik / Contact person - prof. Jyrki Tapio Heinämäki (vastutav/responsible)\nProf. Jyrki Heinämäki, Institute of Pharmacy, room 715, tel. 7375281, email-   jyrki.heinamaki@ut.ee"}, "assessment_scale": {"code": "grade", "et": "Eristav (A, B, C, D, E, F, mi)", "en": "differentiated (A, B, C, D, E, F, not present)"}, "results_available_from": {}}, "resources": {"web_based": {"code": "2", "et": "põimõpe", "en": "blended learning"}, "website_url": "http://www.farmaatsia.ut.ee/et", "is_moodle_connected": true, "learning_environments": [{"uuid": "2436797e-ea1a-4a6d-90f6-78abc95da4da", "type": "MOODLE", "code": "ARFA.02.141_ENG", "base_url": "undefined", "is_auto_update": true, "is_default": true, "is_auto_grading": false}], "mandatory_materials": "- D. Thassu, M. Deleers, Y. V. Pathak (eds.),\nNanoparticulate Drug Delivery Systems, CRC Press, Taylor & Francis Group, Informa Healthcare, New York, 376 p. (the latest edition)\n- I.F. Uchegbu, A.G. Schätzlein, W.P. Cheng, A. Lalatsa (Eds.): Fundamentals of Pharmaceutical Nanoscience, Springer, New York, USA (2013 or the latest edition)."}, "participants": {"lecturers": [{"person_uuid": "af63bf29-b4e4-6576-7c02-cd082986baa6", "person_name": "Karin Kogermann", "structural_unit": {"code": "MVFA", "name": {"en": "Institute of Pharmacy", "et": "farmaatsia instituut"}, "email": "pharmacy@ut.ee", "phone": "+372 737 5286", "webpage_url": "https://farmaatsia.ut.ee", "address": "Nooruse 1\n50411 Tartu linn, \nTartu linn, Tartumaa \nEST", "city": "Tartu linn", "street": "Nooruse 1", "zip": "50411", "level": 2, "academic": true, "supports_continuous_learning": true, "parent_code": "MV"}, "is_responsible": false, "is_teaching": true}, {"person_uuid": "6e2e6079-8350-61b2-7759-5b62569c7119", "person_name": "Andres Lust", "structural_unit": {"code": "MVFA", "name": {"en": "Institute of Pharmacy", "et": "farmaatsia instituut"}, "email": "pharmacy@ut.ee", "phone": "+372 737 5286", "webpage_url": "https://farmaatsia.ut.ee", "address": "Nooruse 1\n50411 Tartu linn, \nTartu linn, Tartumaa \nEST", "city": "Tartu linn", "street": "Nooruse 1", "zip": "50411", "level": 2, "academic": true, "supports_continuous_learning": true, "parent_code": "MV"}, "is_responsible": false, "is_teaching": true}, {"person_uuid": "33421ad8-acc3-91be-5e71-fd5b37451f83", "person_name": "Jyrki Tapio Heinämäki", "structural_unit": {"code": "MVFA", "name": {"en": "Institute of Pharmacy", "et": "farmaatsia instituut"}, "email": "pharmacy@ut.ee", "phone": "+372 737 5286", "webpage_url": "https://farmaatsia.ut.ee", "address": "Nooruse 1\n50411 Tartu linn, \nTartu linn, Tartumaa \nEST", "city": "Tartu linn", "street": "Nooruse 1", "zip": "50411", "level": 2, "academic": true, "supports_continuous_learning": true, "parent_code": "MV"}, "is_responsible": true, "is_teaching": true}]}, "schedule": {"weeks": {"et": "27-38n; 36L,4S => E"}, "entries": [{"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Opening remarks (J.H.)\nIntroduction to Nanoscience and Pharmaceutical nanotechnology\nNanotechnology-based drug delivery systems  (NDDSs) (overview)\t\t\nDelivery of seminar topics and materials"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Pharmaceutical development and fabrication of NDDSs (part I) (J.H.)\n- Nanoparticles/crystals, nanocapsules\n- Nanosuspensions, nanoemulsions, nanogels"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Pharmaceutical development and fabrication of NDDSs (part II) (J.H.)\n- Liposomes\n- Micelles, filomicelles, niosomes, ethosomes\n- Polymersomes\n- Dendrimers"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Pharmaceutical development and preparation of NDDSs (part III) (J.H.)\n- Nanofibers and platforms (nanomats)\n- Biomedical uses of nanomats"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Organelle-specific aspects in Pharmaceutical nanotechnology (J.H.)\n- Subcellular nanomedicine\n- Nanosensors and intracellular environment\n- Uptake and subcellular/intracellular fate of nanodelivery systems\n- Cellular interactions of nanodelivery systems"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Ocular delivery (J.H.)"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Brain & CNS delivery (J.H.)"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Pulmonary delivery (J.H.)"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Antimicrobial agent delivery (K.K.)"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Topical cosmetic & dermal applications (J.H.)"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Transdermal delivery (J.H.)"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Gastrointestinal delivery & applications (J.H.)"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Gene delivery (J.H.)"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Vaccination applications (J.H.)"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Cancer therapy & diagnosis (J.H.)"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Medical imaging (J.H.)"}}, {"work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Medical applications of fullerenes & carbon nanotubes (A.L.)"}}, {"work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Regulatory issues of nanotechnology\nNanotechnology product development & commercialization\nToxicology assessment of NDDSs\n\nFinal seminar (student presentations & discussion)"}}]}, "registration_info": {"audience": {"et": "doktorandid (Doctorete studies), Proviisoriõpe 4, Proviisoriõpe 5, Arstiteadus 3-6, Hambaarstiteadus 3-5"}, "min_students": 3, "max_students": 20}, "parent_uuid": "eaaf0a86-0f05-d0a2-5bd1-1a09bac1920f", "parent_code": "ARFA.02.141", "parent_credits": 4, "_actions": {"is_moodle_editable": false, "is_editable": false, "is_deletable": false}}